Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection

doi:10.3748/wjg.v13.i30.4103

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3160)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

358

HTML

2239

Figures (1-4)

275

Tables (1-4)

288

Sum=3160

Aug 14, 2007 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 14, 2007; 13(30): 4103-4107
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4103

Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection

JS Rajkumar, MG Sekar, SK Mitra

JS Rajkumar, MG Sekar, Lifeline Rigid Hospitals, Kilpauk, Chennai, Tamilnadu 600010, India

SK Mitra, The Himalaya Drug Company, Bangalore 562123, Karnataka, India

Author contributions: All authors contributed equally to the work.

Correspondence to: Dr. SK Mitra, MD, Executive Director, R&D Center, The Himalaya Drug Company, Bangalore-562 123, Karnataka, India. dr.s.k.mitra@himalayahealthcare.com

Telephone: +91-80-23714444 Fax: +91-80-23714471

Received: October 13, 2006
Revised: November 3, 2006
Accepted: November 14, 2006
Published online: August 14, 2007

Core Tip